4//SEC Filing
Pamir Ozan 4
Accession 0001213900-21-013186
CIK 0001690080other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:31 PM ET
Size
6.4 KB
Accession
0001213900-21-013186
Insider Transaction Report
Form 4
Pamir Ozan
Interim CFO
Transactions
- Award
Stock Option (Right to Buy)
2021-02-26+180,000→ 180,000 totalExercise: $4.43Exp: 2031-02-26→ Common Stock (180,000 underlying)
Holdings
- 72,608
Common Stock
Footnotes (2)
- [F1]The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as Interim Chief Financial Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
- [F2]The options vest at the rate of (a) 1/5th of such options on the grant date; and (b) 4/5th of such options vesting ratably on a monthly basis over the following 36 months on the last day of each calendar month, subject to the Reporting Person's continued service to the Company on such vesting dates.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001834681
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:31 PM ET
- Size
- 6.4 KB